Valentí Gómez (V Gomez, Valentí Gomez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Dendritic Cells

Immune Response

Transforming Growth Factor

Top Venues

Science signaling

British journal of clinical pharmacology

Cell death & disease

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jose M Vicencio, R Evans, R Green, Z An, J Deng, C Treacy, R Mustapha, J Monypenny, C Costoya, K Lawler, K Ng, K De-Souza, O Coban, Valentí Gómez, J Clancy, S H Chen, A Chalk, F Wong, P Gordon, C Savage, C Gomes, T Pan, G Alfano, L Dolcetti, J N E Chan, F Flores-Borja, P R Barber, G Weitsman, D Sosnowska, E Capone, S Iacobelli, D Hochhauser, J A Hartley, Maddy Parsons, J N Arnold, Simon M Ameer-Beg, Sergio A Quezada, Yosef Yarden, Gianluca Sala, Tony T Ng
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans. Cell death & disease 13 (3) (2022)
Choon Ping Tan, Laura Sinigaglia, Valentí Gómez, Joanna Nicholls, Nagy A Habib
RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription. Molecules (Basel, Switzerland) 26 (21) (2021)
Valentí Gómez, Thomas R Eykyn, Rami Mustapha, Fabian Flores-Borja, Victoria Male, Paul R Barber, Antonia Patsialou, Ryan Green, Fani Panagaki, Chun W Li, Gilbert O Fruhwirth, Susana Ros, Kevin M Brindle, Tony T Ng
Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells. Science signaling 13 (652) (2020)
Valentí Gómez, Rami Mustapha, Kenrick Ng, Tony T Ng
Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches. British journal of clinical pharmacology 86 (9) (2020)